Nebula Research & Development’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-168,677
Closed -$727K 542
2025
Q2
$727K Buy
168,677
+50,282
+42% +$249K 0.06% 516
2025
Q1
$714K Buy
+118,395
New +$599K 0.07% 490
2024
Q4
Sell
-15,037
Closed -$88K 1034
2024
Q3
$88K Sell
15,037
-22,367
-60% -$110K 0.01% 883
2024
Q2
$161K Sell
37,404
-14,584
-28% -$69.9K 0.03% 745
2024
Q1
$244K Sell
51,988
-148,242
-74% -$568K 0.05% 599
2023
Q4
$983K Buy
200,230
+151,942
+315% +$744K 0.3% 79
2023
Q3
$263K Buy
+48,288
New +$387K 0.14% 317

Other funds holding MPT

Nebula Research & Development's MPT Position: Q3 2025 in Review

Nebula Research & Development sold out of Medical Properties Trust (MPT) in Q3 2025, closing a stake of 168,677 shares — an estimated $727K sold.

Nebula Research & Development first reported a position in MPT in Q3 2023 and held it in 7 quarters. The position peaked at $983K in Q4 2023. 462 funds tracked by Wall St. Rank hold MPT as of Q3 2025.

  • Nebula Research & Development reported no remaining Medical Properties Trust position as of Q3 2025 after selling out during the quarter.
  • Nebula Research & Development sold 168,677 Medical Properties Trust shares in Q3 2025, an estimated $727K.
  • Nebula Research & Development first reported a position in Medical Properties Trust in Q3 2023 and held it in 7 quarters.
  • Nebula Research & Development's Medical Properties Trust position peaked at $983K in Q4 2023.
  • 462 funds tracked by Wall St. Rank held Medical Properties Trust as of Q3 2025.

Based on Nebula Research & Development's 13F filing for Q3 2025.